<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03844568</url>
  </required_header>
  <id_info>
    <org_study_id>B-1809-493-002</org_study_id>
    <nct_id>NCT03844568</nct_id>
  </id_info>
  <brief_title>Nocturnal Nasal Continuous Positive Airway Pressure in Aspiration Pneumonia</brief_title>
  <acronym>NAP</acronym>
  <official_title>Nocturnal Nasal Continuous Positive Airway Pressure in Aspiration Pneumonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Numerous elderly patients are suffering from aspiration pneumonia due to anatomical or
      functional predisposing factors including enteral tube feeding, swallowing difficulties, and
      gastroesophageal reflux disease (GERD). Previous studies have been demonstrated that
      continuous positive airway pressure (CPAP) is an acceptable means of managing chronic
      aspiration, atelectasis, and GERD. The purpose of this study is to determine whether
      nocturnal nasal CPAP is beneficial in patients with aspiration pneumonia and that it would
      contribute to the rapid clinical stability of aspiration pneumonia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 18, 2019</start_date>
  <completion_date type="Anticipated">January 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to clinical stability-respiration (CS-r)</measure>
    <time_frame>up to 2 weeks</time_frame>
    <description>time to respiratory stabilization (respiratory rate ≤ 24/min and arterial oxygen saturation ≥ 90% or a partial pressure of oxygen ≥ 60mmHg on room air or usual requirement level)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to clinical stability</measure>
    <time_frame>up to 2 weeks</time_frame>
    <description>time to clinical stabilization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early clinical stability rate</measure>
    <time_frame>3 days</time_frame>
    <description>day 3 clinical stability rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late clinical stability rate</measure>
    <time_frame>7 days</time_frame>
    <description>day 7 clinical stability rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>1 day (during hospital admission)</time_frame>
    <description>length of hospital admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological improvement</measure>
    <time_frame>3 and 7 days</time_frame>
    <description>improvement of lung infiltration or atelectasis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Broadening of antimicrobial spectrum</measure>
    <time_frame>1 day (during hospital admission)</time_frame>
    <description>escalation antibiotics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of bronchoscopy for toileting</measure>
    <time_frame>1 day (during hospital admission)</time_frame>
    <description>frequency of invasive lung care like bronchoscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>1 day (during hospital admission)</time_frame>
    <description>all cause mortality</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Aspiration Pneumonia</condition>
  <arm_group>
    <arm_group_label>nasal CPAP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Applying nocturnal nasal continuous positive airway pressure in additional to usual pneumonia treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual pneumonia treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nocturnal nasal continuous positive airway pressure</intervention_name>
    <description>applying nasal continuous positive airway pressure at 7.5-10cmH2O for at least 4 hours during nighttime</description>
    <arm_group_label>nasal CPAP group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 65 years

          -  Diagnosis of pneumonia: the presence of new pulmonary infiltration in dependent areas
             on chest radiographs at the time of hospitalization with at least one of the following

               1. New or increased cough

               2. Abnormal temperature (&lt; 35.6℃ or &gt; 37.8℃)

               3. Abnormal serum leukocyte count (leukocytosis, left shift, or leukopenia)

          -  Aspiration tendency or risk factors for frequent or large volume aspiration with at
             least one of the following

               1. Altered mental status

               2. Gastrointestinal disorder

               3. Dysphagia or swallowing difficulties

               4. Esophageal motility disorders

               5. Tracheostomy state

               6. Enteral tube feeding

          -  Informed consent

        Exclusion Criteria:

          -  Severe hypercapnia (PaCO2 &gt; 70mmHg)

          -  Respiratory arrest requiring tracheal intubation

          -  Cardiac arrest, acute coronary syndrome or life threatening arrhythmias

          -  Failure of more than two organs

          -  Recent trauma or burns of the neck and face

          -  Non- cooperation

          -  Pregnancy

          -  Withdrawal of consent

          -  Refusal of treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eun Sun Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eun Sun Kim, MD</last_name>
    <phone>+82-31-787-7086</phone>
    <email>apolio3700@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eun Sun Kim, MD</last_name>
      <phone>+82-31-787-7086</phone>
      <email>apolio3700@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>February 15, 2019</study_first_submitted>
  <study_first_submitted_qc>February 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2019</study_first_posted>
  <last_update_submitted>April 4, 2019</last_update_submitted>
  <last_update_submitted_qc>April 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Eun Sun Kim</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>aspiration pneumonia</keyword>
  <keyword>continuous positive airway pressure, CPAP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Aspiration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

